{"entity":{"type":"insider","cik":"0001991925","url":"/insider/0001991925","json_url":"/insider/0001991925.json","name":"Symetryx Corp","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":3,"first":"2023-09-07","last":"2023-09-18","span_basis":"filed_date"},"name_variants":[{"name":"Symetryx Corp","source":"filing","n_filings":3,"first_seen":"2023-09-07","last_seen":"2023-09-18"}],"transactions":[{"id":8653165,"accession":"0001991925-23-000005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001991925-23-000005","line_url":"/filing/0001991925-23-000005#line-3","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"NeuBase Therapeutics, Inc.","issuer_ticker":"NBSE","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001991925","owner_name":"Symetryx Corp","owner_display_name":"Symetryx Corp","owner_url":"/insider/0001991925","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, Par Value $0.0001 per Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":1.19,"price_display":"1.19","price_state":"stated","total_value":59500.0,"total_display":"59,500.00","total_whole":"59,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-18","filed_date":"2023-09-18","scope":"insider"},{"id":8653163,"accession":"0001991925-23-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001991925-23-000005","line_url":"/filing/0001991925-23-000005#line-2","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"NeuBase Therapeutics, Inc.","issuer_ticker":"NBSE","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001991925","owner_name":"Symetryx Corp","owner_display_name":"Symetryx Corp","owner_url":"/insider/0001991925","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, Par Value $0.0001 per Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103337.0,"shares_display":"103,337","price_per_share":1.26,"price_display":"1.26","price_state":"stated","total_value":130204.62,"total_display":"130,204.62","total_whole":"130,205","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-15","filed_date":"2023-09-18","scope":"insider"},{"id":8653161,"accession":"0001991925-23-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001991925-23-000005","line_url":"/filing/0001991925-23-000005#line-1","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"NeuBase Therapeutics, Inc.","issuer_ticker":"NBSE","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001991925","owner_name":"Symetryx Corp","owner_display_name":"Symetryx Corp","owner_url":"/insider/0001991925","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, Par Value $0.0001 per Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":129108.0,"shares_display":"129,108","price_per_share":1.44,"price_display":"1.44","price_state":"stated","total_value":185915.52,"total_display":"185,915.52","total_whole":"185,916","shares_owned_after":153337.0,"shares_owned_after_display":"153,337","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-14","filed_date":"2023-09-18","scope":"insider"},{"id":8571014,"accession":"0001991925-23-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001991925-23-000003","line_url":"/filing/0001991925-23-000003#line-3","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"NeuBase Therapeutics, Inc.","issuer_ticker":"NBSE","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001991925","owner_name":"Symetryx Corp","owner_display_name":"Symetryx Corp","owner_url":"/insider/0001991925","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, Par Value $0.0001 per Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3376.0,"shares_display":"3,376","price_per_share":1.44,"price_display":"1.44","price_state":"stated","total_value":4861.44,"total_display":"4,861.44","total_whole":"4,861","shares_owned_after":472926.0,"shares_owned_after_display":"472,926","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-11","filed_date":"2023-09-11","scope":"insider"},{"id":8571009,"accession":"0001991925-23-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001991925-23-000003","line_url":"/filing/0001991925-23-000003#line-2","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"NeuBase Therapeutics, Inc.","issuer_ticker":"NBSE","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001991925","owner_name":"Symetryx Corp","owner_display_name":"Symetryx Corp","owner_url":"/insider/0001991925","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, Par Value $0.0001 per Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":128847.0,"shares_display":"128,847","price_per_share":1.53,"price_display":"1.53","price_state":"stated","total_value":197135.91,"total_display":"197,135.91","total_whole":"197,136","shares_owned_after":476302.0,"shares_owned_after_display":"476,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-08","filed_date":"2023-09-11","scope":"insider"},{"id":8571005,"accession":"0001991925-23-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001991925-23-000003","line_url":"/filing/0001991925-23-000003#line-1","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"NeuBase Therapeutics, Inc.","issuer_ticker":"NBSE","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001991925","owner_name":"Symetryx Corp","owner_display_name":"Symetryx Corp","owner_url":"/insider/0001991925","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, Par Value $0.0001 per Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":74852.0,"shares_display":"74,852","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":134733.6,"total_display":"134,733.60","total_whole":"134,734","shares_owned_after":605149.0,"shares_owned_after_display":"605,149","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-07","filed_date":"2023-09-11","scope":"insider"},{"id":8285608,"accession":"0001991925-23-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001991925-23-000002","line_url":"/filing/0001991925-23-000002#line-1","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"NeuBase Therapeutics, Inc.","issuer_ticker":"NBSE","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001991925","owner_name":"Symetryx Corp","owner_display_name":"Symetryx Corp","owner_url":"/insider/0001991925","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, Par Value $0.0001 per Share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":61076.0,"shares_display":"61,076","price_per_share":0.978,"price_display":"0.98","price_state":"stated","total_value":59732.328,"total_display":"59,732.33","total_whole":"59,732","shares_owned_after":680081.0,"shares_owned_after_display":"680,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001173281","name":"NeuBase Therapeutics, Inc.","url":"/issuer/0001173281","role":"Ten percent owner","n_filings":3,"first_seen":"2023-09-07","last_seen":"2023-09-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001991925","retrieved_at":"2026-08-22T23:11:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}